1Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/AC: CP/ATS/SIS International Sepsis Definitions Conference [J].Crit Care Med,2003,31(4): ]250-1256.
2Rivers E-Nguyen B, Havstad S,et al. Early goal-directed therapy inthe treatment of severe sepsis and septic shock[J]. N Engl J Med,2001,345(19): 1368-1377.
3NguyenHB,RiversEP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis andseptic shock[J].Crit CareMed, 2004, 32(8): 1637-1642.
1Rangel Frausto MS,Pitter D,Costigan M,et al.The natural history of the systemic inflammatory syndrome (SIRS):a prospective study[J].JAMA,1995,273(2):117-123.
2Beal AL,Cerra FB.Multiple organ failure syndrome in the 1990s:systemic inflammatory response and organ dysfunction[J].JAMA,1994,271(3):226-233.
3Nguyen HB,Rivers EP,Havstad S,et al.Critical care in the emergency department:a physiologic assessment and outcome evaluation[J].Acad Emerg Med,2000,7(12):1354-1361.
4Elliott DC.An evaluation of the end points of resuscitation[J].J Am Coll Surg,1998,187(5):536-547.
5Gattinoni L,Brazzi L,Pelosi P,et al.A trial of goal-oriented hemodynamic therapy in critically ill patients[J].N Engl J Med,1995,333(16):1025-1032.
6Wallace EL,Churchill WH,Surgenor DM,et al.Collection and transfusion of blood and blood components in the United States,1994[J].Transfusion,1998,38(7):625-636.
7Hébert PC,Wells G,Blajchman MA,et al.A multicenter,randomized,controlled clinical trial of transfusion requirements in critical care[J].N Engl J Med,1999,340(6):409-417.
9Konrad C J,Markl TJ,Schuepfer GK,et al.In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT[J].Anesth Analg,2000,90(2):274-279.
10Trieb J,Baron JF,Graues MT,et al.An international view of hydroxyethyl starches[J].Intensive Care Med,1999,25(3):258-268.
